Latest News about AMGN
Recent news which mentions AMGN
Amgen's Better Than Expected Q1 Earnings Take Backseat As Eyes Are On MariTide Obesity Data
May 02, 2025
From Benzinga
Nasdaq 100 Leads Wall Street Rally As China Signals Openness To Fentanyl Talks, Easing Trade Tensions
May 02, 2025
From Benzinga
Wall Street Eyes 9th Straight Day Of Gains, Apple Falls As Chinese Sales Disappoint: What's Driving Markets Friday?
May 02, 2025
From Benzinga
From Benzinga
Tickers
AMGN
From Motley Fool
Earnings Scheduled For May 1, 2025
May 01, 2025
From Benzinga
From Motley Fool
Stocks Going Ex Dividend In May 2025
April 29, 2025
From TalkMarkets
From Motley Fool
From Motley Fool
From Benzinga
Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React
April 17, 2025
From Benzinga
2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever
April 17, 2025
From Motley Fool
Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug
April 14, 2025
From Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
April 11, 2025
From Benzinga
Rule Breaker Investing: Essays From Yesterday, Vol. 7
April 10, 2025
From Motley Fool
Trump Hints At 'Major Tariff' On Imported Pharmaceuticals: Pfizer, Eli Lilly, Amgen And Other Stocks Tumble In Wednesday Pre-Market
April 09, 2025
From Benzinga
P/E Ratio Insights for Amgen
April 07, 2025
From Benzinga
3 Dividend Stocks to Buy and Hold for the Next Decade
April 06, 2025
From Motley Fool
2 Dividend Stocks to Buy Hand Over Fist in April
April 05, 2025
From Motley Fool
Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks
April 04, 2025
From Benzinga
Nasdaq 100 Enters Bear Market, Dow In Correction Territory, Traders Await Fed Chair Powell's Remarks
April 04, 2025
From Benzinga
FDA Approves Amgen's Uplizna As First Drug For Chronic Immune-Mediated Fibroinflammatory Disorder
April 04, 2025
From Benzinga
From Benzinga
Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday
April 03, 2025
From Motley Fool
From Motley Fool
P/E Ratio Insights for Amgen
April 02, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.